Peaks of Interest
The Gold Editors' Choice Awards was presented to Waters Corporation (Waltham, Massachusetts) for the Synapt HD–MS system at Pittcon 2007 in Chicago, Illinois. Silver Awards were presented to Paraytec (York, United Kingdom) for the ActiPix and Thermo Fisher Scientific (San Jose, California) for the LTQ ETD system. Bronze Awards were presented to Bruker Optics (Billerica, Massachusetts) for the ALPHA FT-IR system and Horiba Jobin Yvon (Edison, New Jersey) for the Activa system.
Pittcon 2007 Editors' Awards
The Gold Editors' Choice Awards was presented to Waters Corporation (Waltham, Massachusetts) for the Synapt HD–MS system at Pittcon 2007 in Chicago, Illinois. Silver Awards were presented to Paraytec (York, United Kingdom) for the ActiPix and Thermo Fisher Scientific (San Jose, California) for the LTQ ETD system. Bronze Awards were presented to Bruker Optics (Billerica, Massachusetts) for the ALPHA FT-IR system and Horiba Jobin Yvon (Edison, New Jersey) for the Activa system.
Many exhibitors regard Pittcon as the premiere industry event and the ideal time and location to introduce advances in analytical instrumentation. Members of the press have acknowledged the numerous products introduced to Pittcon each year by establishing the Pittcon Editors' Awards. Editors meet to nominate, discuss, and contemplate the most significant achievements in the industry. Then they vote on the product to present with the gold, silver, and bronze awards.
Agilent opens center in India
Agilent Technologies, Inc. (Santa Clara, California) announced its intent to establish an R&D center in Bengaluru, India. The center will host a multidisciplinary team for chemical analysis, molecular biology, and software for creating novel and complex scientific applications on its instruments.
The initial focus will be on liquid chromatography and mass spectrometry, but the company hopes to extend the center's focus to include R&D capabilities to other platforms, such as microfluidics, gas chromatography, and microarrays.
Waters collaborates with Hitachi and Shimadzu
Waters Corporation (Waltham, Massachusetts) has announced two significant collaborations.
Waters and Hitachi High-Technologies Corporation (Tokyo, Japan) intend to develop a software interface for Hitachi's LaChrom Elite liquid chromatograph instruments control for Waters Empower chromatographic data station software.
Likewise, Shimadzu Corporation (Kyoto, Japan) intends to collaborate with Waters to develop software that allows the control of Shimadzu's Prominence LC systems using the Waters Empower chromatography software.
These collaborations respond to user needs and will allow the Hitachi and Shimadzu LC systems to be used with Waters' Empower software with seamless control.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
